🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested
CAR T cell immunotherapy has achieved great success in CD19+ B-cell maligna...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02937844
Treatments Being Tested
This is a early Phase 1 open-label, single-arm clinical study of EX02 CAR-T...
Status
Recruiting
Location
The Second Affliated Hospital of Anhui Medical University
Start Date
2024-09-01
Trial ID
NCT06642025
Treatments Being Tested
This study seeks to examine the feasibility and safety of the administratio...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04943016
Treatments Being Tested
Phase 1b open-label study to evaluate the safety of selected TIL (TBio-4101...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2024-03-14
Trial ID
NCT06236425
Treatments Being Tested
Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated act...
Status
Not Yet Recruiting
Location
Boston Children's Hospital
Start Date
2026-10
Trial ID
NCT07729995
Treatments Being Tested
This is a single arm, open-label, dose escalation clinical study to evaluat...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-11-16
Trial ID
NCT03344367
Treatments Being Tested
This is a phase I/II clinical trial of a single dose of CD40L-augmented TIL...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2025-12-03
Trial ID
NCT06961357
Treatments Being Tested
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects w...
Status
Recruiting
Location
Stanford Multiple Sclerosis Center
Start Date
2024-04-10
Trial ID
NCT06138132
Treatments Being Tested